Evidence map›Paper›PMID 36433102›Full record

ArticlePolymers2022

Fast-Processable Non-Flammable Phthalonitrile-Modified Novolac/Carbon and Glass Fiber Composites.

Daria Poliakova, Oleg Morozov, Yakov Lipatov, Alexander Babkin, Alexey Kepman, Viktor Avdeev, Boris Bulgakov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. A Novel Fused SiOPolymers · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daria PoliakovaDivision of Chemical Technology and New Materials, Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory St, 1-11, 119991 Moscow, Russia.
Oleg MorozovDivision of Chemical Technology and New Materials, Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory St, 1-11, 119991 Moscow, Russia.ORCID 0000-0003-3852-1066
Yakov LipatovDivision of Chemical Technology and New Materials, Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory St, 1-11, 119991 Moscow, Russia.
Alexander BabkinDivision of Chemical Technology and New Materials, Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory St, 1-11, 119991 Moscow, Russia.
Alexey KepmanDivision of Chemical Technology and New Materials, Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory St, 1-11, 119991 Moscow, Russia.
Viktor AvdeevDivision of Chemical Technology and New Materials, Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory St, 1-11, 119991 Moscow, Russia.
Boris BulgakovDivision of Chemical Technology and New Materials, Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory St, 1-11, 119991 Moscow, Russia.

Funding

Russian Science Foundation 22-13-00449
6 · The paper itself

Abstract

Phthalonitrile resins (PN) are known for their incredible heat resistance and at the same time poor processability. Common curing cycle of the PN includes dozens hours of heating at temperatures up to 375 °C. This work was aimed at reducing processing time of phthalonitrile resin, and with this purpose, a novolac oligomer with hydroxyl groups fully substituted by phthalonitrile moieties was synthesized with a quantitative yield. Formation of the reaction byproducts was investigated depending on the synthesis conditions. The product was characterized by

Indexed as

compositeheat-resistancemechanical propertiesnon-flammablenovolacphthalonitrile

Identifiers

PMID36433102
PMCPMC9699085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.